Last week, PoCosteo was launched, a project which will work towards the development, clinical validation and preparation for commercialization of a point-of-care tool for the prevention, detection and treatment of bone disease.
The project is supported by the European Union’s Horizon 2020 Framework Programme for Industrial leadership in nanotechnologies, advanced materials, biotechnology and advanced manufacturing and processing (H2020-NMBP).
Ghent University coordinates the project, which involves the following industrial, academic and clinical partners: Universitat Rovira I Virgili and microLIQUID (Spain), Fraunhofer-Gesellschaft zur Förderung der Angewandten Forschung (Germany), Labman Automation (United Kingdom), Medizinische Universität Graz (Austria), Endocrinology and Metabolism Research Institute (Iran) and Fundico (Belgium). The International Osteoporosis Foundation (IOF) supports and advises on the project.
Three research groups from different business development centers (supported by the Industrial Research Fund at Ghent University), are involved in the project: e-POLY, ChemTech Life Sciences and Food2Know.